Text Messaging to Promote Walking Among Latino Adults at Risk for Peripheral Arterial Disease
Text Messaging to Promote Walking Among Latino Adults at Risk for PAD
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Thirty-five million Latinos live in the U.S. and nearly 14% have peripheral arterial disease (PAD) defined as a build-up of plaque in the arteries that supply blood to the legs. Approximately 40% have at least one risk for PAD (i.e., aged 70 years and older, diabetes, high blood pressure, high blood cholesterol, or smoking). Persons with at least one risk factor and who are physically inactive are more likely to suffer from severe PAD. Physical inactivity is highly prevalent in Latinos and a major risk factor for PAD. Physical inactivity affects 50% of Latinos aged 60 years and older.
Participation in this study will last for about 3 months. Participants will be randomized to one of two groups. One group will receive text messages, brief telephone calls, and a handout. The other group will only receive the handout. The study will be looking at how the different groups respond to the different interventions used in the study.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Kansas
-
Wichita, Kansas, Förenta staterna, 67214
- KU School of Medicine - Wichita
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Latino adults
- English or Spanish speaking
- Have one or more of the following: diabetes mellitus, smoking, hypertension, or hyperlipidemia.
- Adults age 70 years or older, regardless of having one or more the above noted risk factors for PAD, will also be eligible for enrollment.
Exclusion Criteria:
- Pregnancy
- Prior major amputation (foot or lower leg) or critical leg ischemia (tissue loss, gangrene, or ulcers)
- Use of supplemental oxygen
- Myocardial infarction within preceding 3 months
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Experimental Group
Participants will receive text messages and telephone calls during the length of their participation.
Participants will receive a handout with information on PAD and physical activity.
|
Text messages will be sent one time per day.
Text messages will include messages to motivate and inform participants on the importance of walking.
Participants may receive a telephone call every two weeks for one month followed by once per month for two months.
Handout includes information specific to participant's condition and ways to promote an active lifestyle.
|
|
Aktiv komparator: Control Group
Participants will receive a handout with information on PAD and physical activity.
|
Handout includes information specific to participant's condition and ways to promote an active lifestyle.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in Physical Activity
Tidsram: Change from Baseline to 3 Months
|
All participants will use a pedometer.
Mean change will be measured based on steps per day.
|
Change from Baseline to 3 Months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in Exercise Behavior
Tidsram: Change from Baseline to 3 Months
|
Change will be measured using the Exercise Behaviors Survey.
|
Change from Baseline to 3 Months
|
|
Change in Quality of Life
Tidsram: Change from Baseline to 3 Months
|
Change will be measured using the Medical Outcomes Study (MOS) Short Form 36.
The survey has 36 questions.
Scores are coded based on response by participant.
A score of 100 indicates the most favorable situation while a score of 0 would indicate the least favorable.
|
Change from Baseline to 3 Months
|
Samarbetspartners och utredare
Samarbetspartners
Utredare
- Huvudutredare: Tracie C. Collins, MD, MPH, University of Kansas Medical Center
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- STUDY00003190
- R56AG047590 (U.S.S. NIH-anslag/kontrakt)
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .